Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process
Board reiterates commitment to improving performance and maximizing stockholder value; has been actively involved in a comprehensive review of a broad range of strategic, operational, and financial alternatives.BELGRADE, Mont., Nov. 16, 2026 // -- Xtant Medical Holdings, Inc. (NYSE Americ…